A California judge recently denied a motion for preliminary approval of a settlement in a Roundup class action. The denial order says the settlement was not reasonable for one group supposedly covered by the settlement; those who used Roundup and have not been diagnosed with Non-Hodgkins Lymphoma (“NHL”).
The court found that the proposed settlement would reduce or eliminate that group to seek appropriate damages if they should develop the disease. It would also require them to submit their claims to medical panels to decide whether Roundup was the direct cause should they develop the disease. The court said a new settlement proposal could be resubmitted if it “…reasonably protects the interests of Roundup users who have not been diagnosed with NHL…”
The case is Ramirez, et al. v. Monsanto Co., Case No. 3:19-cv-02224, In re: Roundup Products Liability Litigation, in the U.S. District Court for the Northern District of California.
This blog is intended to provide information to the general public and to practitioners about developments that may impact Oregon class actions.
Glyphosate, the active ingredient in Monsanto’s Roundup® herbicide, was reported to be “the most important causal factor” in the worldwide increase of gluten intolerance and celiac disease, according to a paper written by MIT scientist Stephanie Seneff and Dr. Anthony Samsel and published by the Journal of Interdisciplinary Toxicology.